Tucked inside the health care bill passed by the state Senate is a provision to study the possibility of a single-payer health care system. The bill's cost control measures are getting all the attention. From the Globe: The 100-page bill attempts to help struggling community hospitals by setting a floor for the reimbursements they receive from … Continue reading Will a legislative study put Massachusetts on the path to single-payer? Supporters head to Beacon Hill to push for it.
Our neighbors to the north have been trying to expand their Medicaid program for years. Lawmakers would endorse it; Republican Gov. Paul LePage would veto it. Apparently that is no longer an option, but he has vowed to find a way. More from The New York Times At least 80,000 additional Maine residents will become eligible … Continue reading Mainers choose Medicaid expansion, but will they get it?
From The Boston Globe: “There is something fundamentally wrong when one of the richest and most powerful countries on the planet can’t make sure that a person can afford to see a doctor when they’re sick. This isn’t any way to live,” Warren wrote, asking her backers to sign a petition expressing their support for … Continue reading Sen. Elizabeth Warren is backing the single-payer insurance proposal from Sen. Bernie Sanders. Does it have a chance?
A Twitter list of 60+ key feeds to help you keep up with the health care debate here and in DC. The two are linked in that the MA program was a model for the ACA. Also, there's an effort ongoing to track and control the costs of care at hospitals. More on that here. … Continue reading How to keep up with the health reform debate in MA and DC: A Twitter list
First: The Globe is getting some attention for its five-part narrative about a family that helped start a drug company to keep their son on an experimental cancer treatment. Nicely written narrative with illustrations and audio. We won't give away the ending. Also, here's what people were saying a year ago about the "21st Century … Continue reading Will 21st Century Cures Act benefit hospitals?
Pharmaceutical manufacturers often look to patient advocates for help winning approval for new drugs. Their most recent success in this area was the FDA’s approval of a new drug for Duchenne muscular dystrophy. That decision came despite recommendations against approval from FDA staff. In an editorial, the Boston Globe questioned the FDA’s move while noting … Continue reading Two Boston meetings look at the role of patient advocates. They offer two very different perspectives.
See Storify for updates. Arnold Relman, the former New England Journal of Medicine editor, has died. From Bryan Marquard at the Globe: Eloquent and forceful on the page or the podium, Dr. Arnold Relman led the New England Journal of Medicine for more than 13 years, raising a sometimes lonely voice to warn about the … Continue reading Former NEJM editor Arnold Relman dies at 91